Scarica l'app Stockscreener
0.728
1.29%
-0.0239
Dopo l'orario di chiusura:
.75
0.022
+3.02%
Precedente Chiudi:
$0.7041
Aprire:
$0.6623
Volume 24 ore:
110.20K
Relative Volume:
0.86
Capitalizzazione di mercato:
$4.66M
Reddito:
$1.10M
Utile/perdita netta:
$-11.23M
Rapporto P/E:
-0.3595
EPS:
-2.025
Flusso di cassa netto:
$-6.61M
1 W Prestazione:
+24.78%
1M Prestazione:
+13.93%
6M Prestazione:
-4.79%
1 anno Prestazione:
-14.41%
Intervallo 1D:
$0.65
$0.7931
Intervallo di 1 settimana:
$0.4838
$0.7931
Portata 52W:
$0.48
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Nome
Matinas Biopharma Holdings Inc
Settore
Industria
Telefono
908-443-1860
Indirizzo
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.728 | 4.51M | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Ripresa | Piper Sandler | Overweight |
| 2020-01-27 | Iniziato | Piper Sandler | Overweight |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2020-01-09 | Iniziato | Aegis Capital | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie
MSN Money - MSN
MTNB Q4 2024 Earnings: Matinas Biopharma Reports Narrower-Than-Expected LossAnalyst Consensus Shift - Newser
MTNB Technical Analysis | Trend, Signals & Chart Patterns | MATINAS BIOPHARMA HOLDINGS I (NYSEARCA:MTNB) - ChartMill
Matinas Biopharma Holdings, Inc. Common Stock (NY: MTNB - The Chronicle-Journal
MTNB Stock Price, Quote & Chart | MATINAS BIOPHARMA HOLDINGS I (NYSEARCA:MTNB) - ChartMill
TradingKey - TradingKey
What Matinas (MTNB) is building for next year | Q4 2024: Earnings Beat EstimatesProfessional Trade Ideas - Newser
Matinas BioPharma (NYSE: MTNB) warns on going concern amid low cash and NYSE notice - Stock Titan
The edge Matinas (MTNB) has in a competitive landscape (-1.09%) 2026-05-08Real Trader Insights - Newser
What Matinas (MTNB) does that makes it resilient (Institutional Selling) 2026-05-08Social Momentum Signals - newser.com
Net current asset value per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Operating cash flow per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Matinas BioPharma Holdings, Inc. (MTNB) - Minichart
Sell Signal: Will Matinas BioPharma Holdings Inc benefit from government policy2026 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Aug Setups: Can Matinas BioPharma Holdings Inc generate free cash flow2026 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
Analyst Upgrade: Can Matinas BioPharma Holdings Inc ride the EV waveJobs Report & Real-Time Volume Analysis - baoquankhu1.vn
Aug Wrap: What are the risks of holding Matinas BioPharma Holdings Inc2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
SHPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Matinas BioPharma Receives NYSE American Non-Compliance Notice Due to Stockholders’ Equity and Ongoing Losses 1 - Minichart
SHPH PE Ratio & Valuation, Is SHPH Overvalued - Intellectia AI
Matinas BioPharma Faces NYSE Compliance Issues - Intellectia AI
Heritage Signs & Displays Completes JD Lewis Center Transformative Branding Project in Raleigh, NC - Weekly Voice
Matinas BioPharma Holdings, Inc. Notifies NYSE American of Non-Compliance with Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline - Stock Titan
Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.49%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):